cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.21353243
title: Elos Program's Efficacy Evaluation in School Management of Child Behavior: A Non-Randomized Controlled Trial

description: Abstract The Elos Program resulted from a Brazilian cultural adaptation of the Good Behavior Game, a preventive strategy for classroom management to reduce aggressive and disruptive behaviors. The goal is to discuss the Elos Program’s efficacy during its implementation in 16 elementary Brazilian public schools in two cities in 2016. The design was a non-randomized controlled trial with 80 classes in each group, experimental and control, involving 1,731 students. The study used the Generalized Estimating Equation model to verify the program's effect. Elos seemed to be effective in reducing aggressiveness and disruptive behavior in boys. These results are aligned with others GBG international studies and suggest that, after a randomized trial, the program would be ready to be disseminated in Brazil.
DOI: 10.6084/m9.figshare.21353243.v1
title: Elos Program's Efficacy Evaluation in School Management of Child Behavior: A Non-Randomized Controlled Trial

description: Abstract The Elos Program resulted from a Brazilian cultural adaptation of the Good Behavior Game, a preventive strategy for classroom management to reduce aggressive and disruptive behaviors. The goal is to discuss the Elos Program’s efficacy during its implementation in 16 elementary Brazilian public schools in two cities in 2016. The design was a non-randomized controlled trial with 80 classes in each group, experimental and control, involving 1,731 students. The study used the Generalized Estimating Equation model to verify the program's effect. Elos seemed to be effective in reducing aggressiveness and disruptive behavior in boys. These results are aligned with others GBG international studies and suggest that, after a randomized trial, the program would be ready to be disseminated in Brazil.
DOI: 10.6084/m9.figshare.21601298
title: Right Ventricle Involvement by Glycogen Storage Cardiomyopathy (PRKAG2): Standard and Advanced Echocardiography Analyses

description: Abstract Background PRKAG2 syndrome is a rare, early-onset autosomal dominant inherited disease. We aimed to describe the right ventricle (RV) echocardiographic findings using two and three-dimensional (2D and 3D) modalities including myocardial deformation indices in this cardiomyopathy. We also aimed to demonstrate whether this technique could identify changes in RV function that could distinguish any particular findings. Methods Thirty patients with genetically proven PRKAG2 (R302Q and H401Q), 16 (53.3%) males, mean age 39.1 ± 15.4 years, underwent complete echocardiography examination. RV-focused, 4-chamber view was acquired for 2D and 3D measurements. Student’s t or Wilcoxon-Mann-Whitney tests were used to compare numerical variables between 2 groups, and p &lt; 0.05 was considered significant. Results Twelve patients (40%) had a pacemaker implanted for 12.4 ± 9.9 years. RV free wall mean diastolic thickness was 7.9 ± 2.9 mm. RV 4-chamber longitudinal strain (RV4LS), including the free wall and interventricular septum, was –17.3% ± 6.7%, and RV free wall longitudinal strain (RVFWLS) was −19.1% ± 8.5%. The RVFWLS apical ratio measured 0.63 ± 0.15. Mean RV 3D ejection fraction (EF) was 42.6% ± 10.9% and below normal limits in 56.7% of patients. Positive correlation occurred between RV 3DEF, RV4LS, and RVFWLS, especially for patients without a pacemaker (p = 0.006). Conclusion RV involvement in PRKAG2 syndrome is frequent, occurring in different degrees. Echocardiography is a valuable tool in detecting RV myocardial abnormalities in this condition. The use of 2D RV4LS, RVFWLS, and 3DEF offers reliable indicators of RV systolic dysfunction in this rare, challenging cardiomyopathy.
DOI: 10.6084/m9.figshare.21601298.v1
title: Right Ventricle Involvement by Glycogen Storage Cardiomyopathy (PRKAG2): Standard and Advanced Echocardiography Analyses

description: Abstract Background PRKAG2 syndrome is a rare, early-onset autosomal dominant inherited disease. We aimed to describe the right ventricle (RV) echocardiographic findings using two and three-dimensional (2D and 3D) modalities including myocardial deformation indices in this cardiomyopathy. We also aimed to demonstrate whether this technique could identify changes in RV function that could distinguish any particular findings. Methods Thirty patients with genetically proven PRKAG2 (R302Q and H401Q), 16 (53.3%) males, mean age 39.1 ± 15.4 years, underwent complete echocardiography examination. RV-focused, 4-chamber view was acquired for 2D and 3D measurements. Student’s t or Wilcoxon-Mann-Whitney tests were used to compare numerical variables between 2 groups, and p &lt; 0.05 was considered significant. Results Twelve patients (40%) had a pacemaker implanted for 12.4 ± 9.9 years. RV free wall mean diastolic thickness was 7.9 ± 2.9 mm. RV 4-chamber longitudinal strain (RV4LS), including the free wall and interventricular septum, was –17.3% ± 6.7%, and RV free wall longitudinal strain (RVFWLS) was −19.1% ± 8.5%. The RVFWLS apical ratio measured 0.63 ± 0.15. Mean RV 3D ejection fraction (EF) was 42.6% ± 10.9% and below normal limits in 56.7% of patients. Positive correlation occurred between RV 3DEF, RV4LS, and RVFWLS, especially for patients without a pacemaker (p = 0.006). Conclusion RV involvement in PRKAG2 syndrome is frequent, occurring in different degrees. Echocardiography is a valuable tool in detecting RV myocardial abnormalities in this condition. The use of 2D RV4LS, RVFWLS, and 3DEF offers reliable indicators of RV systolic dysfunction in this rare, challenging cardiomyopathy.
DOI: 10.3217/v797w-rn585
title: X-ray CT dataset of  a secondary Li-ion Battery

description: X-ray CT scan of a secondary Li-ion Battery by Eduardo Machado, Technical University of Graz. The goal was to observe the impact of mechanical deformation on the layers. Specimen scanned during a laboratory training on March 30, 2002. Isotropic voxel size = 15.5 µm. Please acknowledge Graz micro-computed Tomography Consortium and Eduardo Machado when using this data.
description: Scan Parameters:

Scanner name =TESCAN UnitomXL; 180 kv reflection source; TU_Graz
kV = 175
Target current actual value = 171.7 µA
Target power = 30
Filter = Cu 1.5 mm
Exposure = 280 ms
Projections = 1440
Average = 8
Voxel size = 15.5  µm.
SOD = 57.000076 mm
SDD = 1100.000244 mm
Scan type = smooth take and save
Binning value = 2
Unbinned pixelsize (mm) = 0.15
Binned pixelsize (mm) = 0.3
description: Reconstruction Parameters  (see #.rec.1.xml in directory):

beam hardening correction = 0
Scatter Correction = 0.01
Noise attenuation filter = SheppLogan
Noise attenuation value = 0.5
DOI: 10.48370/ofd/1njygf/6ledm3
title: novel_code_MS_7_11_22.R

description: rscript
DOI: 10.48370/ofd/1njygf/zhpvkb
title: NISZE_BPN_18_11_22.tab

description: raw data
DOI: 10.48370/ofd/1njygf
title: Replication data for "Spatial niche segregation between bird species in the Białowieża National Park (NE Poland)"

description: dataset for peer review process raw data RScript
DOI: 10.11588/data/zptf1x
title: The conditional contribution mechanism for repeated public goods - The general case [Data Replication package]

description: We present a new and simple mechanism for repeated public good environments. In the Conditional Contribution Mechanism (CCM), agents send two messages of the form, “I am willing to contribute x units to the public good if in total y units are contributed.” This mechanism offers agents risk-free strategies, which we call unexploitable. Our main theorem states that all outcomes of the CCM will eventually be Pareto efficient if agents choose unexploitable better responses. We conduct a laboratory experiment to investigate whether observed behavior is consistent with this prediction. In the complete information case we find that indeed almost 80% of outcomes are Pareto optimal. Furthermore, in comparison to the Voluntary Contribution Mechanism, the CCM leads to significantly higher contribution rates. Even under incomplete information, contributions are fairly high and do not deteriorate over time, although surprisingly the VCM does equally well in this case. Theoretically, allowing agents to send two messages helps them ensure the status-quo and at the same time offer higher contribution levels. In a further treatment, where we allow agents to send only one message, we find that total contributions are consistently lower than the CCM in early periods but are similar in later periods.
DOI: 10.5519/qd.hfrdqybh
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (1001 records)
DOI: 10.24403/jp.1267629
title: Förderung der Fairness im Fußball durch den Einsatz des Video-Schiedsrichterassistenten – eine utilitaristische Perspektive
DOI: 10.24403/jp.1267631
title: Die Europäische Super Liga – gewünscht oder verteufelt? Eine Analyse am Beispiel deutscher Fußballfans
DOI: 10.6084/m9.figshare.21601410
title: Additional file 12 of Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis

description: Additional file 12: Table S1. Differentially Expressed Genes in Microglia, RE vs CTRL.
DOI: 10.6084/m9.figshare.21601410.v1
title: Additional file 12 of Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis

description: Additional file 12: Table S1. Differentially Expressed Genes in Microglia, RE vs CTRL.
DOI: 10.6084/m9.figshare.21601413.v1
title: Additional file 13 of Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis

description: Additional file 13: Table S2. Differentially Expressed Genes in Microglia, RE vs FCD.
DOI: 10.6084/m9.figshare.21601416
title: Additional file 14 of Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis

description: Additional file 14: Table S3. Top Highly Differentially Expressed Genes in Microglia Subpopulations.
DOI: 10.6084/m9.figshare.21601416.v1
title: Additional file 14 of Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis

description: Additional file 14: Table S3. Top Highly Differentially Expressed Genes in Microglia Subpopulations.
DOI: 10.6084/m9.figshare.21601413
title: Additional file 13 of Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis

description: Additional file 13: Table S2. Differentially Expressed Genes in Microglia, RE vs FCD.
DOI: 10.6084/m9.figshare.21601419
title: Additional file 15 of Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis

description: Additional file15: Table S4. Top 100 Differentially Expressed Genes Across Pseudotime Trajectories.
DOI: 10.6084/m9.figshare.21601419.v1
title: Additional file 15 of Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis

description: Additional file15: Table S4. Top 100 Differentially Expressed Genes Across Pseudotime Trajectories.
DOI: 10.6084/m9.figshare.21601389
title: dataset_20221122.docx

description: This data for the review study
DOI: 10.6084/m9.figshare.21601389.v1
title: dataset_20221122.docx

description: This data for the review study
DOI: 10.5281/zenodo.7243575
title: Dataset of GxE paper

description: This repository contains dataset of GxE paper. Genotype data Phenotype data Weather data RIL population name is RIL1 ... N12 RIL2 ... N11 RIL3 ... N05 RIL4 ... N18 RIL5 ... N17
DOI: 10.5281/zenodo.7213803
title: Dataset of GxE paper

description: This repository contains dataset of GxE paper. Genotype data Phenotype data Weather data RIL population name is RIL1 ... N12 RIL2 ... N11 RIL3 ... N05 RIL4 ... N18 RIL5 ... N17
DOI: 10.25921/mctv-qe20
title: ES60 Water Column Sonar Data Collected During EBS18AK
DOI: 10.6084/m9.figshare.21601458
title: Review Study dataset

description: This is our dataset.
DOI: 10.6084/m9.figshare.21601458.v1
title: Review Study dataset

description: This is our dataset.
DOI: 10.21227/a4gc-ng46
title: Dataset of alarm deadband design based on maximum amplitude deviations

description: This is a data set of delay timer design for paper ''Alarm deadband design based on maximum amplitude deviations and Bayesian estimation''.
DOI: 10.5281/zenodo.7345554
title: Dataset Literatur Review on Cyberlaw OR and motorcycles

description: Dataset Literatur Review On Cyberlaw and motorcylces
DOI: 10.5281/zenodo.7345553
title: Dataset Literatur Review on Cyberlaw OR and motorcycles

description: Dataset Literatur Review On Cyberlaw and motorcylces
DOI: 10.6084/m9.figshare.21601518
title: data.sav

description: Data in SPSS
DOI: 10.21227/v31v-ed32
title: Dataset of alarm deadband design based on maximum amplitude deviations

description: This is a data set of alarm deadband design for paper ''Alarm deadband design based on maximum amplitude deviations and Bayesian estimation''.
DOI: 10.34740/kaggle/dsv/4562889
title: AutoXGB
DOI: 10.6084/m9.figshare.20581566
title: Supplementary Material for: A Retrospective Chart Review of 809 Patients With Physician-Diagnosed Essential Thrombocythemia Receiving Cytoreductive Therapy in US Community Oncology Practices

description: Introduction: This analysis reports demographic and clinical characteristics of patients with physician-diagnosed essential thrombocythemia (ET) receiving cytoreductive therapy in US community clinical practice. Methods: Patient characteristics, medical history, diagnostic test results, signs/symptoms, treatment patterns, and physician practice settings were extracted from medical charts for patients with physician-diagnosed ET receiving cytoreductive therapy. Results: Among 809 patients (51.1% female; 75.4% White; median age, 69 years) from 50 community practices, 64.5% had physician-reported diagnosis per World Health Organization criteria. Only 48.8% underwent diagnostic bone marrow biopsies; 87.5% had JAK2 mutation testing. Among those tested, 512/708 (72.3%), 57/213 (26.8%), and 37/213 (17.4%) had JAK2, CALR, and MPL mutations, respectively. Of physician-assigned risk assessments, 41.8% were misclassifications based on data-derived risk assessment. Most patients (93.3%) received first-line hydroxyurea (HU) cytoreductive therapy. Discontinuations were primarily for intolerance (35.4%) and resistance (23.8%). Of those who discontinued, 65.9% received no subsequent therapy and had higher ET symptom rates at last visit versus patients continuing HU (48.8% vs 25.0%). Conclusion: This study shows notable gaps in ET diagnosis and management. Half of patients were diagnosed without bone marrow biopsy, many received incorrect risk assignment, and the majority who discontinued HU received no subsequent therapy despite continued need.
DOI: 10.6084/m9.figshare.20581566.v1
title: Supplementary Material for: A Retrospective Chart Review of 809 Patients With Physician-Diagnosed Essential Thrombocythemia Receiving Cytoreductive Therapy in US Community Oncology Practices

description: Introduction: This analysis reports demographic and clinical characteristics of patients with physician-diagnosed essential thrombocythemia (ET) receiving cytoreductive therapy in US community clinical practice. Methods: Patient characteristics, medical history, diagnostic test results, signs/symptoms, treatment patterns, and physician practice settings were extracted from medical charts for patients with physician-diagnosed ET receiving cytoreductive therapy. Results: Among 809 patients (51.1% female; 75.4% White; median age, 69 years) from 50 community practices, 64.5% had physician-reported diagnosis per World Health Organization criteria. Only 48.8% underwent diagnostic bone marrow biopsies; 87.5% had JAK2 mutation testing. Among those tested, 512/708 (72.3%), 57/213 (26.8%), and 37/213 (17.4%) had JAK2, CALR, and MPL mutations, respectively. Of physician-assigned risk assessments, 41.8% were misclassifications based on data-derived risk assessment. Most patients (93.3%) received first-line hydroxyurea (HU) cytoreductive therapy. Discontinuations were primarily for intolerance (35.4%) and resistance (23.8%). Of those who discontinued, 65.9% received no subsequent therapy and had higher ET symptom rates at last visit versus patients continuing HU (48.8% vs 25.0%). Conclusion: This study shows notable gaps in ET diagnosis and management. Half of patients were diagnosed without bone marrow biopsy, many received incorrect risk assignment, and the majority who discontinued HU received no subsequent therapy despite continued need.
DOI: 10.6084/m9.figshare.21601587
title: Supplementary table S1

description: Supplementary table S1 belonging to Metagenomic analysis of anaerobic methylated quaternary amine metabolism in anoxic marine sediments by Peter Q Fischer et al.
DOI: 10.6084/m9.figshare.21601587.v1
title: Supplementary table S1

description: Supplementary table S1 belonging to Metagenomic analysis of anaerobic methylated quaternary amine metabolism in anoxic marine sediments by Peter Q Fischer et al.
DOI: 10.6084/m9.figshare.21563673
title: Supplementary table S2

description: Supplementary table S2 belonging to "Metagenomic analysis of anaerobic methylated quaternary amine metabolism in anoxic marine sediments" by Peter Q. Fischer et al.
DOI: 10.6084/m9.figshare.21563673.v1
title: Supplementary table S2

description: Supplementary table S2 belonging to "Metagenomic analysis of anaerobic methylated quaternary amine metabolism in anoxic marine sediments" by Peter Q. Fischer et al.
DOI: 10.6084/m9.figshare.19558762
title: Genome-level analyses resolve an ancient lineage of symbiotic ascomycetes (Dataset)

description: Dataset from Diaz-Escandón <em>et a</em>l. Genome-level analyses resolve an ancient lineage of symbiotic ascomycetes. Currrent Biology(2022), https://doi.org/10.1016/j.cub.2022.11.014 <br> <strong>1_Assembly</strong>: All new generated genomes, quality control, and scripts used. <strong>2_Phylogenomics</strong>: All the alignments, trees, and supporting analyses. <strong>3_Annotations</strong>: A set of 115 functional annotated genomes, steps to annotate them and a comparisson step. <strong>4_Comparative_statistics</strong>: A set of R scripts and curated data from annotations, including figure assets, statistics, and tables. <br>
DOI: 10.6084/m9.figshare.19558762.v1
title: Genome-level analyses resolve an ancient lineage of symbiotic ascomycetes (Dataset)

description: Dataset from Diaz-Escandón <em>et a</em>l. Genome-level analyses resolve an ancient lineage of symbiotic ascomycetes. Currrent Biology(2022), https://doi.org/10.1016/j.cub.2022.11.014 <br> <strong>1_Assembly</strong>: All new generated genomes, quality control, and scripts used. <strong>2_Phylogenomics</strong>: All the alignments, trees, and supporting analyses. <strong>3_Annotations</strong>: A set of 115 functional annotated genomes, steps to annotate them and a comparisson step. <strong>4_Comparative_statistics</strong>: A set of R scripts and curated data from annotations, including figure assets, statistics, and tables. <br>
DOI: 10.5281/zenodo.7346378
title: Scripts for the paper entitled "Comment on 'Climate consequences of hydrogen emissions' by Ocko and Hamburg (2022)"

description: This repository contains scripts used to generate equations and results in the paper "Comment on 'Climate consequences of hydrogen emissions' by Ocko and Hamburg (2022)". Please contact the corresponding author for any questions: Lei Duan (leiduan@carnegiescience.edu)
DOI: 10.6084/m9.figshare.21601203.v1
title: Supplementary Material for: Trends of Blood Transfusion According to Diseases in Korea: A 10-Year Nationwide Cohort Study

description: <b><i>Introduction:</i></b> Recent guidelines recommend restrictive red blood cell transfusion; therefore, hospitals have started introducing and implementing patient blood management programs. This is the first study to analyze changes in the trends of blood transfusions in the whole population over the past 10 years according to sex, age group, blood component, disease, and hospital type. <b><i>Methods:</i></b> This cohort study analyzed blood transfusion records for 10 years, from January 2009 to December 2018, using nationwide population-based data from the Korean National Health Insurance Service-Health Screening Cohort database. <b><i>Results:</i></b> The proportion of transfusion procedures conducted in the total population has increased constantly for 10 years. Although its proportion in the age group of 10–79 years decreased, the total number of transfusions increased significantly due to the increase in the population and proportion of transfusions in those aged 80 years or older. Furthermore, the proportion of multicomponent transfusion procedures increased in this age group, which was greater than that of transfusions. The most common disease among transfusion patients in 2009 was cancer, of which gastrointestinal (GI) cancer accounted for more than half, followed by trauma and hematologic diseases (GI cancers &gt; trauma &gt; other cancers &gt; hematologic diseases). The proportion of patients with GI cancer decreased, whereas that of trauma and hematologic diseases increased over the 10 years, with trauma becoming the most common disease type in 2018 (trauma &gt; GI cancers &gt; hematologic diseases &gt; other cancers). Although transfusion rates per hospitalization decreased, the total number of inpatients increased, thus increasing the number of blood transfusions in all types of hospitals. <b><i>Discussion/Conclusions:</i></b> The proportion of transfusion procedures in the total population increased owing to the increase in the total number of transfusions in patients aged 80 years or older. The proportion of patients with trauma and hematologic diseases has also increased. Moreover, the total number of inpatients has been increasing, which subsequently increases the number of blood transfusions performed. Specific management strategies targeting these groups may improve blood management.